Diligence memo · auto-generated · as of July 3, 2026
Vivacelle Bio, Inc.
Vivacelle Bio, Inc. has raised $4.2M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Vivacelle Bio, Inc. operates in Biotech / Pharma, based in Evanston.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Vivacelle Bio, Inc. has raised $4.2M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.9M on 2016-08-05.
Most recent recorded round closed around 2016-08-05.
Valuation (modeled)modeled
Provath models Vivacelle Bio, Inc. at approximately $120M (range $2.1M–$938M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 9.9 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 29.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 46% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 73% of those peers.
Closest niche peers: Recreo Pharmaceuticals Llc, ClearLight Biotechnologies, LLC, Base Pair Biotechnologies, Inc..
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.